Literature DB >> 29588114

Post marathon cardiac troponin T is associated with relative exercise intensity.

A J Richardson1, T Leckie2, E R Watkins3, D Fitzpatrick4, R Galloway5, R Grimaldi5, P Baker6.   

Abstract

OBJECTIVES: This study aimed to investigate whether measures of cardiopulmonary fitness and relative exercise intensity were associated with high sensitivity cardiac troponin T (cTnT) rise after a road marathon.
METHODS: Fifty-two marathon runners (age 39±11 years, body mass 76.2±12.9kg, height 1.74±0.09m) attended the laboratory between 2 and 3 weeks prior to attempting the Brighton Marathon, UK. Running economy at 10kmh-1 (RE10) and race pace (RERP), ventilatory threshold (VT) and VO2max tests were completed. CTnT was measured within 48h prior to the marathon and within 10min of completing the marathon, using a high sensitivity assay. Heart rates (HR) were recorded throughout the marathon.
RESULTS: Runners demonstrated a significant increase in cTnT over the marathon (pre-race 5.60±3.27ngL-1, post-race 74.52±30.39ngL-1, p<0.001). Markers of endurance performance such as running economy (10kmh-1 223±18mlkg-1km-1; race pace 225±22mlkg-1km-1), VT (38.5±6.4mlkg-1min-1) and V˙O2max (50.9±7.7mlkg-1min-1) were not associated with post-race cTnT. Runners exercise intensity correlated with post-race cTnT (mean HR %VT 104±5%, r=0.50; peak HR %VT 118±8%, r=0.68; peak HR %V˙O2max 96±6, r=0.60, p<0.05) and was different between the low, medium and high cTnT groups (p<0.05).
CONCLUSIONS: CTnT increases above reference limits during a marathon. Magnitude of cTnT rise is related to exercise intensity relative to ventilatory threshold and V˙O2max, but not individuals' absolute cardiopulmonary fitness, training state or running history.
Copyright © 2018 Sports Medicine Australia. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cardiopulmonary fitness; Endurance; Heart; Running; Stress

Mesh:

Substances:

Year:  2018        PMID: 29588114     DOI: 10.1016/j.jsams.2018.02.005

Source DB:  PubMed          Journal:  J Sci Med Sport        ISSN: 1878-1861            Impact factor:   4.319


  6 in total

1.  Two-peaked increase of serum myosin heavy chain-α after triathlon suggests heart muscle cell death.

Authors:  Tom Danielsson; Hendrik Schreyer; Hanna Woksepp; Therese Johansson; Patrick Bergman; Alf Månsson; Jörg Carlsson
Journal:  BMJ Open Sport Exerc Med       Date:  2019-01-21

2.  Kinetics, Moderators and Reference Limits of Exercise-Induced Elevation of Cardiac Troponin T in Athletes: A Systematic Review and Meta-Analysis.

Authors:  Feifei Li; Will G Hopkins; Xuejing Wang; Julien S Baker; Jinlei Nie; Junqiang Qiu; Binh Quach; Kun Wang; Longyan Yi
Journal:  Front Physiol       Date:  2021-03-26       Impact factor: 4.566

3.  Determinants of Interindividual Variation in Exercise-Induced Cardiac Troponin I Levels.

Authors:  Magnus Bjørkavoll-Bergseth; Christine Bjørkvik Erevik; Øyunn Kleiven; Thijs M H Eijsvogels; Øyvind Skadberg; Vidar Frøysa; Tomasz Wiktorski; Bjørn Auestad; Thor Edvardsen; Kristin Moberg Aakre; Stein Ørn
Journal:  J Am Heart Assoc       Date:  2021-08-28       Impact factor: 5.501

4.  Effects of Matched Intermittent and Continuous Exercise on Changes of Cardiac Biomarkers in Endurance Runners.

Authors:  Feifei Li; Jinlei Nie; Haifeng Zhang; Frank Fu; Longyan Yi; Will Hopkins; Yang Liu; Yifan Lu
Journal:  Front Physiol       Date:  2020-01-31       Impact factor: 4.566

5.  Exercise Preconditioning Plays a Protective Role in Exhaustive Rats by Activating the PI3K-Akt Signaling Pathway.

Authors:  Jingjing Li; Peng Xu; Yang Wang; Zheng Ping; Xuebin Cao; Yu Zheng
Journal:  Evid Based Complement Alternat Med       Date:  2020-01-21       Impact factor: 2.629

Review 6.  The Main Causes and Mechanisms of Increase in Cardiac Troponin Concentrations Other Than Acute Myocardial Infarction (Part 1): Physical Exertion, Inflammatory Heart Disease, Pulmonary Embolism, Renal Failure, Sepsis.

Authors:  Aleksey Chauin
Journal:  Vasc Health Risk Manag       Date:  2021-09-21
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.